Immunotherapy for EGFR-mutant advanced non-small-cell lung cancer: Current status, possible mechanisms and application prospects

Overview of attention for article published in Frontiers in immunology, July 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 3 news outlets

Readers on

mendeley: 22 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

Diagnosed with Non-Small-Cell Lung Cancer? Here’s Why You Need Biomarker Testing

Everyday Health, 06 May 2024

Navigating Non-Small-Cell Lung Cancer Testing for biomarkers can uncover more about the specific type of lung cancer you have…

Searching for New Solutions in Treating EGFR-Mutant NSCLC

Health Reporter, 27 Jun 2023

Searching for New Solutions in Treating EGFR-Mutant NSCLC

AJMC, 27 Jun 2023

Worldwide, about 2.2 million people are diagnosed with lung cancer each year; between 80% and 85% of these cases are non–small…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.